EDP Biotech EDP Biotech Corporation is an in vitro diagnostic device company focused on the development and commercialization of blood-based immunodiagnostic assays. | ![]() Breathomix Breathomix is a company that provides solutions to diagnose and manage respiratory diseases, including asthma, COPD (chronic obstructive pulmonary disease), and lung cancer. | ![]() AroCell AroCell AB is an in vitro diagnostics company focusing on the monitoring of hematological malignancies, breast cancer, and other solid tumors. | ||
Founding Date | Founding Date 2005 | Founding Date 2005 | Founding Date 2018 | Founding Date 2003 |
Type | Type Public | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Isfiya, IL HQ New York, US | Locations Knoxville, US HQ | Locations Leiden, NL HQ | Locations Uppsala, SE HQ |
Employees | Employees 85 | Employees 24 | Employees 2 | Employees 22 |
Valuation ($) | Valuation ($) 7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 11 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr43m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods (kr397k) (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit kr43.9m (FY, 2023) |
Net income | Net income ($17.6m) (FY, 2023) | Net income N/A | Net income N/A | Net income (kr59.3m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 39.3m | Total funding raised $ 200k | Total funding raised N/A | Total funding raised $ 56.1k |
EDP Biotech Corporation is an in vitro diagnostic device company focused on the development and commercialization of blood-based immunodiagnostic assays.
View companyBreathomix is a company that provides solutions to diagnose and manage respiratory diseases, including asthma, COPD (chronic obstructive pulmonary disease), and lung cancer.
View companyAroCell AB is an in vitro diagnostics company focusing on the monitoring of hematological malignancies, breast cancer, and other solid tumors.
View company